5 Analysts Have This to Say About Waters
Benzinga · 4d ago
Barclays Adjusts Waters Price Target to $380 From $340, Maintains Overweight Rating
Barclays Adjusts Waters Price Target to $380 From $340, Maintains Overweight Rating
MT Newswires · 4d ago
Goldman tips stocks poised to best benefit from China's reopening
Seeking Alpha · 5d ago
Bruker Corp.: My Top Ranked Holding In Laboratory Analytical Instruments
Seeking Alpha · 01/19 08:50
NIH outlays fall, US govt healthcare grants grow but Biopharma financings decline Y/Y
Seeking Alpha · 01/18 17:03
Evoqua Water Technologies: Great Results Do Not Translate To A Great Prospect
Seeking Alpha · 01/11 00:00
BMEZ: Biotech Fund Generated High Yield Last Year, But Seems Unsustainable
Seeking Alpha · 01/08 11:38
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 01/06 18:16
SVB Securities Sticks to Their Hold Rating for Waters (WAT)
TipRanks · 01/06 16:25
Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday
Benzinga · 01/06 16:17
Healthcare Stocks Sell Off Friday -- WSJ
The Wall Street Journal · 01/06 15:36
SVB Leerink Maintains Market Perform on Waters, Raises Price Target to $352
Benzinga · 01/06 14:10
SVB Securities Adjusts Waters's Price Target to $352 From $320, Keeps Market Perform Rating
SVB Securities Adjusts Waters's Price Target to $352 From $320, Keeps Market Perform Rating
MT Newswires · 01/06 10:59
Tracking Terry Smith's Fundsmith 13F Portfolio - Q3 2022 Update
Seeking Alpha · 01/01 07:49
This Favorable Sign Appears On Waters's Chart
Benzinga · 12/21/2022 14:50
4 Analysts Have This to Say About Waters
Benzinga · 12/14/2022 16:03
Deutsche Bank Initiates Coverage On Waters with Hold Rating, Announces Price Target of $350
Benzinga · 12/14/2022 09:59
Here’s Why Diamond Hill Capital Shorted Waters Corporation (WAT)
Diamond Hill Capital, an investment management company, released its “Long-Short Fund” third-quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy returned -5.25% compared to a -4.61% return for the Rus...
Insider Monkey · 12/02/2022 03:33
Insider Sell: Waters Corp
Insider Sell: Waters Corp
MT Newswires · 12/01/2022 12:43
Investors in Waters (NYSE:WAT) have made a favorable return of 70% over the past five years
Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking...
Simply Wall St. · 11/29/2022 16:30
Webull provides a variety of real-time WAT stock news. You can receive the latest news about Waters through multiple platforms. This information may help you make smarter investment decisions.
About WAT
Waters Corporation is a specialty measurement company that primarily designs, manufactures, sells and services high performance liquid chromatography (HPLC) ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company’s segments include Waters and TA. The Waters operating segment is designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instruments, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA operating segment designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments. The Company's LC and LC-MS instruments are utilized in a range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify compounds.